Table 3.
Kaplan-Meier univariate survival analysis of KIRREL and other clinicopathological parameters in gastric cancer patients.
| Clinicopathological parameters | Mean survival time (months) | 95% CI | P value |
|---|---|---|---|
| KIRREL levels | |||
| Low | 70.630 | 63.748–77.511 | 0.000 |
| High | 34.907 | 26.001–43.812 | |
| Age (years) | |||
| ≤60 | 51.862 | 41.117–62.607 | 0.678 |
| >60 | 48.478 | 38.583–58.373 | |
| Gender | |||
| Male | 49.938 | 41.512–58.364 | 0.965 |
| Female | 49.485 | 34.937–64.032 | |
| CEA (ng/ml) | |||
| ≤10 | 53.364 | 43.084–63.644 | 0.363 |
| >10 | 46.560 | 36.324–56.797 | |
| CA199 (U/ml) | |||
| ≤37 | 48.706 | 39.047–58.365 | 0.754 |
| >37 | 51.824 | 40.864–62.783 | |
| Tumor location | |||
| Antrum | 52.858 | 41.392–64.324 | 0.420 |
| Other sites | 47.725 | 38.344–57.106 | |
| Tumor size (cm) | |||
| ≤5 | 61.286 | 52.272–70.301 | 0.000 |
| >5 | 35.336 | 25.623–45.048 | |
| Histological differentiation | |||
| Well/moderate | 56.106 | 47.039–65.173 | 0.048 |
| Poor | 41.709 | 30.392–53.026 | |
| T stage | |||
| T1–2 | 67.477 | 58.545–76.410 | 0.002 |
| T3–4 | 41.437 | 32.506–50.369 | |
| N stage | |||
| N0 | 63.561 | 53.703–73.420 | 0.008 |
| N1–3 | 42.075 | 32.851–51.299 | |
| TNM stage | |||
| I–II | 66.234 | 58.174–74.295 | 0.000 |
| III–IV | 36.256 | 26.695–45.818 | |